Search Results - "Koke, C."

Fluoxetine versus sertraline and paroxetine in major depressive disorder : Changes in weight with long-term treatment by FAVA, Maurizio, JUDGE, Rajinder, HOOG, Sharon L, NILSSON, Mary E, KOKE, Stephanie C

“…The effects of extended selective serotonin reuptake inhibitor (SSRI) treatment on weight are not well characterized. Also unknown is whether different agents…”
Get full text

A Placebo-Controlled Study of Fluoxetine in Continued Treatment of Bulimia Nervosa After Successful Acute Fluoxetine Treatment by Romano, Steven J., Halmi, Katherine A., Sarkar, Neena P., Koke, Stephanie C., Lee, Julia S.

“…OBJECTIVE: The efficacy of fluoxetine in the acute management of bulimia nervosa is well established; however, few controlled studies have examined whether…”
Get full text

Fluoxetine versus placebo in posttraumatic stress disorder by MARTENYI, Ferenc, BROWN, Eileen B, ZHANG, Harry, PRAKASH, Apurva, KOKE, Stephanie C

“…This study was designed to address the efficacy and tolerability of fluoxetine in patients with posttraumatic stress disorder (PTSD) as diagnosed using the…”
Get full text

Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder by Martenyi, Ferenc, Brown, Eileen B., Zhang, Harry, Koke, Stephanie C., Prakash, Apurva

“…Little is known about the effect of pharmacotherapy in the prevention of post-traumatic stress disorder (PTSD) relapse. To assess the efficacy and tolerability…”
Get full text

Pharmacotherapy for stress urinary incontinence: Present and future options by ZINNER, Norman R, KOKE, Stephanie C, VIKTRUP, Lars

“…Stress urinary incontinence (SUI) is the accidental leakage of urine associated with physical activities such as running, jumping or lifting, or with sneezing…”
Get full text

Adverse events and treatment discontinuations in clinical trials of fluoxetine in major depressive disorder: An updated meta-analysis by Beasley, Charles M., Koke, Stephanie C., Nilsson, Mary E., Gonzales, Jill S.

“…Background: A 1993 meta-analysis of US Investigational New Drug clinical trials of fluoxetine reinforced this agent's more favorable adverse-event profile…”
Get full text

Efficacy, adverse events, and treatment discontinuations in fluoxetine clinical studies of major depression : A meta-analysis of the 20-mg/day dose by BEASLEY, Charles M, NILSSON, Mary E, KOKE, Stephanie C, GONZALES, Jill S

“…The efficacy and safety of fluoxetine in adults with moderate-to-severe major depression are well established. However, most analyses combined dosages (20-80…”
Get full text

Safety and efficacy of fluoxetine in patients who receive oral contraceptive therapy by Koke, Stephanie C., Brown, Eileen B., Miner, Cherri M.

“…Objective: Because many women who receive pharmacologic therapy with antidepressants are also prescribed oral contraceptives, it is important to assess the…”
Get full text

Changes in energy during treatment of depression : An analysis of fluoxetine in double-blind, placebo-controlled trials by JUDGE, Rajinder, PLEWES, John M, KUMAR, Vinod, KOKE, Stephanie C, KOPP, Joan B

“…More than two thirds of patients with depression present with symptoms of fatigue, low energy, and listlessness. Because daytime sedation may be a concern in…”
Get full text

The Sternberg Triarchic Abilities Test (STAT) as a measure of academic achievement and general intelligence by Koke, Lena C., Vernon, Philip A.

“…The degree to which practical, creative, and analytical abilities, measured by the Sternberg Triarchic Abilities Test (STAT) (Sternberg, 1993), significantly…”
Get full text

Defining treatment-emergent adverse events with the medical dictionary for regulatory activities (MedDRA) by NILSSON, Mary E, KOKE, Stephanie C

Get full text

Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: The absence of an effect related to agitation and suicidal behavior by Wernicke, Joachim F., Sayler, Mary E., Koke, Stephanie C., Pearson, Donna K., Tollefson, Gary D.

“…Concomitant use of psychoactive medications is a common practice in most clinical trials of antidepressant medications. However, the relative therapeutic…”
Get full text

Fluoxetine vs. tricyclic antidepressants in women with major depressive disorder by Lewis-Hall, F C, Wilson, M G, Tepner, R G, Koke, S C

“…Major depressive disorder and dysthymia are twice as prevalent in women as in men, and the lifetime risk of a woman's developing a major depressive disorder is…”
Get more information

Pattern representation and recognition with accelerated analog neuromorphic systems by Petrovici, M. A., Schmitt, S., Klahn, J., Stockel, D., Schroeder, A., Bellec, G., Bill, J., Breitwieser, O., Bytschok, I., Grubl, A., Guttler, M., Hartel, A., Hartmann, S., Husmann, D., Husmann, K., Jeltsch, S., Karasenko, V., Kleider, M., Koke, C., Kononov, A., Mauch, C., Muller, E., Muller, P., Partzsch, J., Pfeil, T., Schiefer, S., Scholze, S., Subramoney, A., Thanasoulis, V., Vogginger, B., Legenstein, R., Maass, W., Schuffny, R., Mayr, C., Schemmel, J., Meier, K.

“…Despite being originally inspired by the central nervous system, artificial neural networks have diverged from their biological archetypes as they have been…”
Get full text

Dirac equation in 2-dimensional curved spacetime, particle creation, and coupled waveguide arrays by Koke, C, Noh, C, Angelakis, D. G

“…Annals of Physics 375 (2016) 162-178 When quantum fields are coupled to gravitational fields, spontaneous particle creation may occur similarly to when they…”
Get full text

Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder by Martenyi, F, Brown, E B, Zhang, H, Koke, S C, Prakash, A

“…Assessed the efficacy and tolerability of fluoxetine in preventing PTSD relapse. Used a double-blind, randomised, placebo-controlled study. Concludes that…”
Get full text

Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder by MARTENYI, Ferenc, BROWN, Eileen B, ZHANG, Harry, KOKE, Stephanie C, PRAKASH, Apurva

Get full text